1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Nielsen, J.T. Bjerring, M. Jeppesen, M.D. Pedersen, R.O. Pedersen, J.M. Hein, K.L. Vosegaard, T. Skrydstrup, T. Otzen, D.E. Nielsen, N. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking GE Angew.Chem.Int.Ed.Engl. 9999 1433-7851 48 2118 2121 10.1002/anie.200804198 19130518 Unique identification of supramolecular structures in amyloid fibrils by solid-state NMR spectroscopy. 2009 720.815 NFGAIL segment from human islet amyloid polypeptide 8 syn polymer no no NFGAILS NFGAILS A,B,C,D,E,F,G,H polypeptide(L) n n n n n n n database_2 pdbx_database_status pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Data collection Database references Derived calculations Other 1 0 2009-09-08 1 1 2011-07-13 1 2 2020-02-26 _pdbx_database_status.status_code_cs _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model BMRB Y RCSB 2009-05-01 REL REL REL structures with the lowest energy 1000 10 0.049 NCA NCO 2D 13C-13C DARR 2.5 ms mixing 2D 13C-13C DARR 5 ms mixing 2D 13C-13C DARR 20 ms mixing 2D 13C-13C DARR 40 ms mixing 2D 13C-13C DARR 100 ms mixing 2D 13C-13C DARR 200 ms mixing 2.5 mg/mL [U-100% 13C; U-100% 15N] 7.2 ambient 263 K torsion angle dynamics 1 lowest energy 2.5 mg/mL [U-100% 13C; U-100% 15N] NFGAIL, 100% H2O 100% H2O Schwieters, C.D. et al. refinement X-PLOR NIH 2.18 700 Bruker AVANCE Bruker Avance ASN 1 n 1 ASN 1 A PHE 2 n 2 PHE 2 A GLY 3 n 3 GLY 3 A ALA 4 n 4 ALA 4 A ILE 5 n 5 ILE 5 A LEU 6 n 6 LEU 6 A SER 7 n 7 SER 7 A ASN 1 n 1 ASN 1 B PHE 2 n 2 PHE 2 B GLY 3 n 3 GLY 3 B ALA 4 n 4 ALA 4 B ILE 5 n 5 ILE 5 B LEU 6 n 6 LEU 6 B SER 7 n 7 SER 7 B ASN 1 n 1 ASN 1 C PHE 2 n 2 PHE 2 C GLY 3 n 3 GLY 3 C ALA 4 n 4 ALA 4 C ILE 5 n 5 ILE 5 C LEU 6 n 6 LEU 6 C SER 7 n 7 SER 7 C ASN 1 n 1 ASN 1 D PHE 2 n 2 PHE 2 D GLY 3 n 3 GLY 3 D ALA 4 n 4 ALA 4 D ILE 5 n 5 ILE 5 D LEU 6 n 6 LEU 6 D SER 7 n 7 SER 7 D ASN 1 n 1 ASN 1 E PHE 2 n 2 PHE 2 E GLY 3 n 3 GLY 3 E ALA 4 n 4 ALA 4 E ILE 5 n 5 ILE 5 E LEU 6 n 6 LEU 6 E SER 7 n 7 SER 7 E ASN 1 n 1 ASN 1 F PHE 2 n 2 PHE 2 F GLY 3 n 3 GLY 3 F ALA 4 n 4 ALA 4 F ILE 5 n 5 ILE 5 F LEU 6 n 6 LEU 6 F SER 7 n 7 SER 7 F ASN 1 n 1 ASN 1 G PHE 2 n 2 PHE 2 G GLY 3 n 3 GLY 3 G ALA 4 n 4 ALA 4 G ILE 5 n 5 ILE 5 G LEU 6 n 6 LEU 6 G SER 7 n 7 SER 7 G ASN 1 n 1 ASN 1 H PHE 2 n 2 PHE 2 H GLY 3 n 3 GLY 3 H ALA 4 n 4 ALA 4 H ILE 5 n 5 ILE 5 H LEU 6 n 6 LEU 6 H SER 7 n 7 SER 7 H author_defined_assembly 8 octameric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 C O PHE 2 C O PHE 2 A N LEU 6 A N LEU 6 A N ILE 5 A N ILE 5 E O GLY 3 E O GLY 3 E N PHE 2 E N PHE 2 G O LEU 6 G O LEU 6 D O PHE 2 D O PHE 2 B N LEU 6 B N LEU 6 B N ILE 5 B N ILE 5 F O GLY 3 F O GLY 3 F N PHE 2 F N PHE 2 H O LEU 6 H O LEU 6 NFGAIL segment from human islet amyloid polypeptide Protein Fibril 1 N N 1 N N 1 N N 1 N N 1 N N 1 N N 1 N N 1 N N PROTEIN FIBRIL Protein fibril, IAPP, Amylin, SNNFGAILSS, Symmetry 2KIB PDB 1 2KIB 1 7 2KIB 1 7 2KIB A 1 1 7 1 7 2KIB 1 7 2KIB B 1 1 7 1 7 2KIB 1 7 2KIB C 1 1 7 1 7 2KIB 1 7 2KIB D 1 1 7 1 7 2KIB 1 7 2KIB E 1 1 7 1 7 2KIB 1 7 2KIB F 1 1 7 1 7 2KIB 1 7 2KIB G 1 1 7 1 7 2KIB 1 7 2KIB H 1 1 7 4 4 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel C PHE 2 C PHE 2 C LEU 6 C LEU 6 A PHE 2 A PHE 2 A LEU 6 A LEU 6 E PHE 2 E PHE 2 E LEU 6 E LEU 6 G PHE 2 G PHE 2 G LEU 6 G LEU 6 D PHE 2 D PHE 2 D LEU 6 D LEU 6 B PHE 2 B PHE 2 B LEU 6 B LEU 6 F PHE 2 F PHE 2 F LEU 6 F LEU 6 H PHE 2 H PHE 2 H LEU 6 H LEU 6